Alfonso Amat, CEO & Co-Founder

Alfonso is an entrepreneur and technology executive with 28 years of experience building and scaling successful ventures. After graduating in the top 10 of his Electronic Engineering class, he quickly rose to managing major IT projects at 22 and pioneering data center services across Latin America for a Fidelity Investments-backed startup at 24. At Telefónica, he grew the convergent business 20x in five years as Head of Product Marketing. In 2012, Alfonso founded IAMAT, developing AI and real-time interaction systems for clients including Verizon, the Olympic Games Committee, and managing Lionel Messi's global digital presence, leading to a successful acquisition by Globant (NYSE: GLOB) in 2018. After six years at AWS developing Latin America's startup ecosystem, Alfonso has returned to his early passion at the intersection of technology and biology by co-founding CellRep, which builds innovative platforms to make cell therapies more accessible and effective.

Federico Perdomo Celis, CSO & Co-Founder

Medical Doctor and PhD in Immunology, with Postdoctoral training at Institut Pasteur, Paris. He is a renowned immunologist, with a large publication record on the study of the immune response to viral infections and tumors, with a particular focus on the T cell response. By studying the mechanisms of HIV control in the absence of antiretroviral therapy, he developed a system to reprogram T cells to improve their functional capacity.

Manuel Franco Cortés, CCO & Co-Founder

Medical Doctor and PhD in Immunology, with Postdoctoral training at Stanford University. He has long-term experience in vaccine and immunotherapy studies to improve the efficacy of T cell responses.

Julian Ganzabal, CAIO & Co-Founder

Electronic Engineer. Experienced Machine Learning Engineer. Specialiced in the full ML lifecycle (MLOps), model design, and development. Professor at the Instituto Tecnológico de Buenos Aires (ITBA), where he co-directs and teaches the Deep Learning degree program. With over 25 years of experience, Julian is dedicated to advancing AI-driven solutions in biomedical research and beyond

Prof. Luca Gattinoni, Advisor

Luca Gattinoni, M.D. holds the Chair for Functional Immune Cell Modulation at the University of Regensburg and directs the Division at the Leibniz Institute for Immunotherapy. He earned his medical degree from the University of Milan (1998) and completed oncology residency at Milan's National Cancer Institute (2003). At the U.S. National Cancer Institute, he conducted postdoctoral research under Dr. Nicholas Restifo (2003–2008), then served as Staff Scientist (2008–2013) and Stadtman Investigator (2013–2019). His research focuses on harnessing T cells to treat cancer. He discovered human stem cell memory T cells (Tscm) and translates this into clinical adoptive cell therapy strategies. His lab explores molecular and metabolic mechanisms underlying T cell stemness to improve immunotherapy effectiveness. He has published over 100 papers and received the SITC Presidential Award (2004), Wilson S. Stone Memorial Award (2012), and NCI Director's Intramural Innovation Award (2013).